{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:29:48Z","timestamp":1791847788218,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00270-022-03116-z","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:03:01Z","timestamp":1648670581000},"page":"1102-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-2079","authenticated-orcid":false,"given":"Minhtuan","family":"Nguyenhuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Maingard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kuan","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Jhamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"issue":"7","key":"3116_CR1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624\u201333.","journal-title":"Cancer"},{"issue":"1","key":"3116_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","volume":"113","author":"U Pastorino","year":"1997","unstructured":"Pastorino U, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37\u201349.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"3116_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1148\/radiol.2402050807","volume":"240","author":"T de Baere","year":"2006","unstructured":"de Baere T, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587\u201396.","journal-title":"Radiology"},{"issue":"1","key":"3116_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2214\/ajr.174.1.1740057","volume":"174","author":"DE Dupuy","year":"2000","unstructured":"Dupuy DE, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174(1):57\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3116_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13244-021-00997-5","volume":"12","author":"A Paez-Carpio","year":"2021","unstructured":"Paez-Carpio A, et al. Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art. Insights Imaging. 2021;12(1):57.","journal-title":"Insights Imaging"},{"issue":"5","key":"3116_CR6","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/S0012-3692(15)52923-1","volume":"128","author":"CL Nguyen","year":"2005","unstructured":"Nguyen CL, et al. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005;128(5):3507\u201311.","journal-title":"Chest"},{"issue":"7","key":"3116_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","volume":"9","author":"R Lencioni","year":"2008","unstructured":"Lencioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621\u20138.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3116_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4103\/atm.ATM_392_17","volume":"13","author":"B Jiang","year":"2018","unstructured":"Jiang B, et al. Efficacy and safety of thermal ablation of lung malignancies: a Network meta-analysis. Ann Thorac Med. 2018;13(4):243\u201350.","journal-title":"Ann Thorac Med"},{"issue":"5","key":"3116_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"issue":"3","key":"3116_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176\u201381.","journal-title":"Semin Radiat Oncol"},{"issue":"15","key":"3116_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1002\/sim.6111","volume":"33","author":"C Combescure","year":"2014","unstructured":"Combescure C, Foucher Y, Jackson D. Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects. Stat Med. 2014;33(15):2521\u201337.","journal-title":"Stat Med"},{"issue":"4","key":"3116_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"7414","key":"3116_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"3116_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"3116_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.ejso.2017.08.005","volume":"43","author":"TA Bin Traiki","year":"2017","unstructured":"Bin Traiki TA, et al. Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43(10):1939\u201348.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3116_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12020-020-02580-2","volume":"72","author":"F Bonichon","year":"2021","unstructured":"Bonichon F, et al. Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network. Endocrine. 2021;72(3):798\u2013808.","journal-title":"Endocrine"},{"issue":"7","key":"3116_CR17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","volume":"15","author":"MR Callstrom","year":"2020","unstructured":"Callstrom MR, et al. Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE). J Thorac Oncol. 2020;15(7):1200\u20139.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re T, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987\u201391.","journal-title":"Ann Oncol"},{"issue":"11","key":"3116_CR19","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.jtho.2021.07.021","volume":"16","author":"T de Baere","year":"2021","unstructured":"de Baere T, et al. The ECLIPSE study: efficacy of cryoablation on metastatic lung tumors with a 5-year follow-up. J Thorac Oncol. 2021;16(11):1840\u20139.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3116_CR20","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1186\/s12885-019-6345-2","volume":"19","author":"A Gonnet","year":"2019","unstructured":"Gonnet A, et al. Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience. BMC Cancer. 2019;19(1):1182.","journal-title":"BMC Cancer"},{"issue":"3","key":"3116_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1148\/radiol.2020191272","volume":"294","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa T, et al. Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: a prospective multicenter study. Radiology. 2020;294(3):686\u201395.","journal-title":"Radiology"},{"issue":"6","key":"3116_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jvir.2011.02.030","volume":"22","author":"T Hiraki","year":"2011","unstructured":"Hiraki T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan. J Vasc Interv Radiol. 2011;22(6):741\u20138.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"3116_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtcvs.2005.12.051","volume":"131","author":"M Kawamura","year":"2006","unstructured":"Kawamura M, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131(5):1007\u201313.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3116_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00270-013-0644-9","volume":"37","author":"C Koelblinger","year":"2014","unstructured":"Koelblinger C, Strauss S, Gillams A. Outcome after radiofrequency ablation of sarcoma lung metastases. Cardiovasc Intervent Radiol. 2014;37(1):147\u201353.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"3116_CR25","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1245\/s10434-021-09714-4","volume":"28","author":"KS Leppelmann","year":"2021","unstructured":"Leppelmann KS, et al. Outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma of the head and neck: a bi-institutional retrospective cohort study. Ann Surg Oncol. 2021;28(11):5829\u201339.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3116_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jvir.2014.11.013","volume":"26","author":"Y Matsui","year":"2015","unstructured":"Matsui Y, et al. Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases. J Vasc Interv Radiol. 2015;26(3):303\u201310.","journal-title":"J Vasc Interv Radiol"},{"issue":"16","key":"3116_CR27","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/cncr.24420","volume":"115","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer. 2009;115(16):3774\u201381.","journal-title":"Cancer"},{"issue":"9","key":"3116_CR28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jvir.2016.05.017","volume":"27","author":"K Omae","year":"2016","unstructured":"Omae K, et al. Long-term survival after radiofrequency ablation of lung oligometastases from five types of primary lesions: a retrospective evaluation. J Vasc Interv Radiol. 2016;27(9):1362\u201370.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"3116_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.athoracsur.2009.05.012","volume":"88","author":"A Pennathur","year":"2009","unstructured":"Pennathur A, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg. 2009;88(5):1601\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"3116_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11604-016-0601-z","volume":"35","author":"T Sato","year":"2017","unstructured":"Sato T, et al. Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients. Jpn J Radiol. 2017;35(2):61\u20137.","journal-title":"Jpn J Radiol"},{"issue":"1","key":"3116_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1148\/radiol.2431060088","volume":"243","author":"CJ Simon","year":"2007","unstructured":"Simon CJ, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243(1):268\u201375.","journal-title":"Radiology"},{"issue":"6","key":"3116_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1464-410X.2009.08459.x","volume":"104","author":"N Soga","year":"2009","unstructured":"Soga N, et al. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. BJU Int. 2009;104(6):790\u20134.","journal-title":"BJU Int"},{"issue":"1","key":"3116_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.diii.2020.09.006","volume":"102","author":"L Tselikas","year":"2021","unstructured":"Tselikas L, et al. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease. Diagn Interv Imaging. 2021;102(1):19\u201326.","journal-title":"Diagn Interv Imaging"},{"issue":"16","key":"3116_CR34","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/cncr.25958","volume":"117","author":"EM von Meyenfeldt","year":"2011","unstructured":"von Meyenfeldt EM, et al. Local progression after radiofrequency ablation for pulmonary metastases. Cancer. 2011;117(16):3781\u20137.","journal-title":"Cancer"},{"issue":"3","key":"3116_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jvir.2006.11.003","volume":"18","author":"K Yamakado","year":"2007","unstructured":"Yamakado K, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18(3):393\u20138.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"3116_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3892\/or_00000513","volume":"22","author":"K Yamakado","year":"2009","unstructured":"Yamakado K, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep. 2009;22(4):885\u201391.","journal-title":"Oncol Rep"},{"issue":"5","key":"3116_CR37","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1245\/s10434-006-9271-x","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, et al. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol. 2007;14(5):1718\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"3116_CR38","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1007\/s00270-020-02623-1","volume":"43","author":"J Zhong","year":"2020","unstructured":"Zhong J, et al. Long-term outcomes in percutaneous radiofrequency ablation for histologically proven colorectal lung metastasis. Cardiovasc Intervent Radiol. 2020;43(12):1900\u20137.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"24","key":"3116_CR39","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815\u201334.","journal-title":"Stat Med"},{"key":"3116_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.publhealth.18.1.83","volume":"18","author":"KM Leung","year":"1997","unstructured":"Leung KM, Elashoff RM, Afifi AA. Censoring issues in survival analysis. Annu Rev Public Health. 1997;18:83\u2013104.","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"3116_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12916-017-0900-y","volume":"15","author":"DR Caswell","year":"2017","unstructured":"Caswell DR, Swanton C. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med. 2017;15(1):133.","journal-title":"BMC Med"},{"issue":"3","key":"3116_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/1759-7714.12973","volume":"10","author":"YD Sun","year":"2019","unstructured":"Sun YD, et al. Efficacy of radiofrequency ablation and microwave ablation in the treatment of thoracic cancer: a systematic review and meta-analysis. Thorac Cancer. 2019;10(3):543\u201350.","journal-title":"Thorac Cancer"},{"issue":"2","key":"3116_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ejcts\/ezx092","volume":"52","author":"R Dziedzic","year":"2017","unstructured":"Dziedzic R, et al. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry. Eur J Cardiothorac Surg. 2017;52(2):363\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5 Suppl","key":"3116_CR44","doi-asserted-by":"publisher","first-page":"e278S","DOI":"10.1378\/chest.12-2359","volume":"143","author":"JA Howington","year":"2013","unstructured":"Howington JA, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S-e313S.","journal-title":"Chest"},{"issue":"9","key":"3116_CR45","doi-asserted-by":"publisher","first-page":"e1581","DOI":"10.1002\/onco.13802","volume":"26","author":"GCL Gossling","year":"2021","unstructured":"Gossling GCL, et al. Outcomes and prognostic factors of patients with metastatic colorectal cancer who underwent pulmonary metastasectomy with curative intent: a Brazilian experience. Oncologist. 2021;26(9):e1581\u20138.","journal-title":"Oncologist"},{"issue":"10","key":"3116_CR46","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1097\/JTO.0b013e3182287da2","volume":"6","author":"K Hornbech","year":"2011","unstructured":"Hornbech K, Ravn J, Steinbruchel DA. Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002\u20132006. J Thorac Oncol. 2011;6(10):1733\u201340.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3116_CR47","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.21037\/jtd.2019.12.12","volume":"11","author":"C Cao","year":"2019","unstructured":"Cao C, et al. A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases. J Thorac Dis. 2019;11(12):5187\u201398.","journal-title":"J Thorac Dis"},{"key":"3116_CR48","first-page":"ED000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"3116_CR49","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.7150\/jca.32205","volume":"10","author":"LM Hess","year":"2019","unstructured":"Hess LM, et al. Relationship between progression-free survival and overall survival in randomized clinical trials of targeted and biologic agents in oncology. J Cancer. 2019;10(16):3717\u201327.","journal-title":"J Cancer"},{"issue":"9","key":"3116_CR50","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jtho.2017.05.015","volume":"12","author":"JE Lodeweges","year":"2017","unstructured":"Lodeweges JE, et al. Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases. J Thorac Oncol. 2017;12(9):1442\u20135.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"3116_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5761\/atcs.ra.18-00229","volume":"25","author":"FP Cheung","year":"2019","unstructured":"Cheung FP, Alam NZ, Wright GM. The past, present and future of pulmonary metastasectomy: a review article. Ann Thorac Cardiovasc Surg. 2019;25(3):129\u201341.","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"4","key":"3116_CR52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.4103\/jcrt.JCRT_364_18","volume":"15","author":"J Liu","year":"2019","unstructured":"Liu J, et al. The application of computed tomography-guided percutaneous coaxial biopsy combined with microwave ablation for pulmonary tumors. J Cancer Res Ther. 2019;15(4):760\u20135.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"3116_CR53","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00330-016-4447-7","volume":"27","author":"L Tselikas","year":"2017","unstructured":"Tselikas L, et al. Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation. Eur Radiol. 2017;27(3):1211\u20137.","journal-title":"Eur Radiol"},{"issue":"10","key":"3116_CR54","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/codi.15113","volume":"22","author":"M Milosevic","year":"2020","unstructured":"Milosevic M, et al. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients\u2014control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314\u201324.","journal-title":"Colorectal Dis"},{"issue":"10185","key":"3116_CR55","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138.","journal-title":"Lancet"},{"key":"3116_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx015","author":"T Ruers","year":"2017","unstructured":"Ruers T, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017. https:\/\/doi.org\/10.1093\/jnci\/djx015.","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"3116_CR57","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1001\/jama.299.22.2667","volume":"299","author":"SE Harrington","year":"2008","unstructured":"Harrington SE, Smith TJ. The role of chemotherapy at the end of life: \u201cwhen is enough, enough?\u201d JAMA. 2008;299(22):2667\u201378.","journal-title":"JAMA"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T19:45:45Z","timestamp":1658519145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03116-z","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"14 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare(s) that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}